Sensex fell 1747.08 points or 3.00% to 56,405.84 and Nifty was down by 531.95 points or 3.06% to 16,842.80 in the previous session. Sensex touched high and low of 57,191.91 and 56,295.70, respectively. There was 1 stock advancing against 29 stocks declining on the index. Nifty traded in a range of 17,099.50 and 16,809.65 and there was 1 stock advancing against 49 stocks declining on the index.

Mahalaxmi Rubtech, SEL Manufacturing Company, Sejal Glass, Focus Lighting and Fixtures, Mukand Engineers, Crest Ventures, Shree Ram Proteins, and D B Realty have made fresh 52 weeks high on Monday.

RattanIndia Enterprises has announced the launch of its all-digital, financial aggregator platform, BankSe on the popular Android mobile platform and through the web portal www.bankse.in. At launch, it is partnering with large commercial banks and NBFCs in India to present maiden offerings in the personal loans, two-wheeler loans and credit card segments, with several more categories to be added subsequently.

Aarti Surfactants Limited, AGS Transact Technologies Limited, Amara Raja Batteries Limited, Apollo Pipes Limited, and Asian Granito India Limited have hit a 52-week low on Monday.

Asian Energy Services along with its JV partner has secured a materials handling project worth Rs 128 crore including GST from Coal India subsidiary Eastern Coalfields Ltd for building and operating a coal handling plant for Hura C OCP.

IDEA, JPPOWER, YESBANK, HCC, PNB, SUZLON, ADANIPOWER, BANKBARODA, GTLINFRA, and ONGC were the most active equities on NSE.

KPI Global Infrastructure has informed the exchange that it has received an order for executing a solar power project of 16 MWdc capacity from M/s Aether Industries Limited, Surat under the captive power producer (CPP) segment of the company. 

DSP Mutual Fund – DSP Nifty 50 ETF, S&S Power Switchgears Limited, UFLEX Limited, Visaka Industries Limited, and Subros Limited were the top volume gainers.

Glenmark Pharmaceuticals announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and Astrazeneca Colombia S.A.S. have entered into an exclusive licensing agreement for the commercialization of AstraZeneca’s drug Pulmicort Respules.

AARVI, ANSAL API, ARTNIRMAN, BLUECHIP, and BVCL hit the upper price band while 20MICRONS, 21STCENMGM, 3IINFOLTD, 3PLAND, and 63MOONS hit the lower price band. There were 41 securities that hit the upper band while 328 hit the lower band on February 14, 2022.